G1 Therapeutics Announces Upcoming Presentation at the 2024 American Society of Clinical Oncology (ASCO) Meeting
May 23, 2024 17:06 ET
|
G1 Therapeutics
G1 Therapeutics Announces Upcoming Presentation at the 2024 American Society of Clinical Oncology (ASCO) Meeting
G1 Therapeutics to Participate in TD Cowen’s 5th Annual Oncology Innovation Summit
May 22, 2024 10:00 ET
|
G1 Therapeutics
G1 Therapeutics to Participate in TD Cowen’s 5th Annual Oncology Innovation Summit
G1 Therapeutics and Deimos Biosciences Announce Global (Excluding Asia-Pacific) License Agreement for Lerociclib for Radioprotective Uses
May 22, 2024 06:30 ET
|
G1 Therapeutics
G1 Therapeutics and Deimos Biosciences Announce Global (Excluding Asia-Pacific) License Agreement for Lerociclib for Radioprotective Uses
G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 01, 2024 17:50 ET
|
G1 Therapeutics
G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
G1 Therapeutics Provides First Quarter 2024 Financial Results and Operational Highlights
May 01, 2024 06:30 ET
|
G1 Therapeutics
G1 Therapeutics Provides First Quarter 2024 Financial Results and Operational Highlights
G1 Therapeutics and Pepper Bio Announce Global (Excluding Asia-Pac) License Agreement for Lerociclib
May 01, 2024 06:25 ET
|
G1 Therapeutics
G1 Therapeutics and Pepper Bio Announce Global (Excluding Asia-Pac) License Agreement for Lerociclib
G1 Therapeutics to Release First Quarter 2024 Financial Results and Provide Business Update on May 1, 2024
April 17, 2024 09:00 ET
|
G1 Therapeutics
G1 Therapeutics to Release First Quarter 2024 Financial Results and Provide Business Update on May 1, 2024
G1 Therapeutics to Participate in the 23rd Annual Needham Virtual Healthcare Conference
April 04, 2024 10:30 ET
|
G1 Therapeutics
G1 Therapeutics to Participate in the 23rd Annual Needham Virtual Healthcare Conference
G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 01, 2024 16:20 ET
|
G1 Therapeutics
G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 01, 2024 16:20 ET
|
G1 Therapeutics
G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)